JP2003513935A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513935A5
JP2003513935A5 JP2001536186A JP2001536186A JP2003513935A5 JP 2003513935 A5 JP2003513935 A5 JP 2003513935A5 JP 2001536186 A JP2001536186 A JP 2001536186A JP 2001536186 A JP2001536186 A JP 2001536186A JP 2003513935 A5 JP2003513935 A5 JP 2003513935A5
Authority
JP
Japan
Prior art keywords
biotype
mycoplasma bovis
inactivated
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513935A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/042000 external-priority patent/WO2001034189A2/en
Publication of JP2003513935A publication Critical patent/JP2003513935A/ja
Publication of JP2003513935A5 publication Critical patent/JP2003513935A5/ja
Pending legal-status Critical Current

Links

JP2001536186A 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法 Pending JP2003513935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
US60/164,286 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (2)

Publication Number Publication Date
JP2003513935A JP2003513935A (ja) 2003-04-15
JP2003513935A5 true JP2003513935A5 (enExample) 2007-12-27

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536186A Pending JP2003513935A (ja) 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法

Country Status (10)

Country Link
US (7) US7943153B1 (enExample)
EP (1) EP1229929A2 (enExample)
JP (1) JP2003513935A (enExample)
AU (1) AU782508B2 (enExample)
BR (1) BR0015398A (enExample)
CA (1) CA2390613A1 (enExample)
IL (1) IL149471A0 (enExample)
MX (1) MXPA02004627A (enExample)
WO (1) WO2001034189A2 (enExample)
ZA (1) ZA200203622B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1420636A2 (en) * 2001-08-28 2004-05-26 Pfizer Products Inc. Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
ME01000B (me) * 2007-11-06 2012-10-20 Zoetis Services Llc Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
NZ589981A (en) * 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
AU2009309041B2 (en) 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
KR20170077255A (ko) 2009-06-04 2017-07-05 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신
EP2485764A4 (en) 2009-10-09 2014-01-29 Childrens Medical Center SELECTIVELY DISCONNECTED FULL CELL VACCINE
WO2012041635A1 (en) * 2010-09-29 2012-04-05 Universite De Liege Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
US11369671B2 (en) 2012-09-10 2022-06-28 Galenbio, Inc. Vaccine to prevent mycoplasmal infections in waterfowl
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
CN116751723A (zh) * 2023-07-24 2023-09-15 吉林农业大学 一种牛支原体菌株及其灭活疫苗和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164143D1 (en) 1980-07-01 1984-07-19 Nat Res Dev Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose, L.L.C. Impfung von tieren mit getrockneten pelletierten biologischen materialien
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Similar Documents

Publication Publication Date Title
JP2003513935A5 (enExample)
RU2349342C2 (ru) Менингококковые вакцины для введения через слизистую оболочку
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
NO20015073D0 (no) Vaksiner
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
AR020050A1 (es) COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE LA ENFERMEDAD AMILOIDOGENICA USO DE UN PÉPTIDO ABETA PARA LA PREPARACIoN DE MEDICAMENTOS
US9200259B2 (en) Canine coronavirus vaccine
UY27366A1 (es) Vacunación en dosis única con mycoplasma hyopneumoniae
JP2004536106A5 (enExample)
WO2001034189A3 (en) Vaccines for mycoplasma bovis and methods of use
Stephen et al. Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys
US5928649A (en) Method of reversing immunosuppression in vaccines
EP3076997B1 (en) Swine vaccine against prrs and lawsonia intracellularis
JP2009514840A5 (enExample)
JPH0840927A (ja) 肺炎球菌抗原の経粘膜投与方法
US11167021B2 (en) Vaccine for protection against Streptococcus suis
JP2003519089A (ja) 肺炎球菌表面型蛋白質配合ワクチン
EP1237573B1 (fr) Utilisation de proteines immunogenes immunosuppressives ou angiogeniques rendues inactives pour la production d'lga secretoires
CN116115746A (zh) 含有木鳖子总皂苷和铝盐的疫苗佐剂及其疫苗组合物
Cohen et al. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries
RU2227160C1 (ru) Штамм бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
RU2291709C1 (ru) Способ иммунопрофилактики вирусных респираторных болезней телят
Salmon Humoral lactogenic immunity in the sow: basis and practice.
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant
DE60141681D1 (de) Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen